Teladoc Health Inc. (TDOC) saw its stock soar by a remarkable 8.76% in Tuesday's pre-market trading session, driven by the announcement of a new collaboration with Amazon (AMZN) to expand access to Teladoc's industry-leading chronic condition management programs.
The partnership allows eligible Amazon customers to seamlessly discover and enroll in Teladoc's cardiometabolic programs for diabetes, hypertension, pre-diabetes, and weight management directly through Amazon's Health Benefits Connector. This move aims to improve access to needed care and help people manage their health in an easier and more convenient way.
"This partnership helps deliver on our strategy to bring greater value to our customers in our individual solutions and across our integrated offerings," said Chuck Divita, Chief Executive Officer of Teladoc Health. "By enabling customers to discover and enroll in our programs on Amazon, this effort will improve access to needed care and help people manage their health in an easier and more convenient way."
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.